ck2 inhibitor ttp 22 (Santa Cruz Biotechnology)
Structured Review
Ck2 Inhibitor Ttp 22, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 88/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ttp+22/TTP+22/pm30249660-237-1-35
Average 88 stars, based on 2 article reviews
Images
Related Articles
other:Article Title: Role for ERK1/2-dependent activation of FCHSD2 in cancer cell-selective regulation of clathrin-mediated endocytosis. Article Snippet: The CK2 inhibitor TTP 22 (1 μM), the MLCK inhibitor ML-7 HCl (3 μM), the mTOR inhibitor rapamycin (10 nM), the p38 inhibitor SB239063 (450 nM), and the Article Title: ERK1/2-dependent activation of FCHSD2 drives cancer cell-selective regulation of clathrin-mediated endocytosis Article Snippet: The CK2 inhibitor TTP 22 (1 μM), the MLCK inhibitor ML-7 HCl (3 μM), the mTOR inhibitor rapamycin (10 nM), the p38 inhibitor SB239063 (450 nM) and the Article Title: Role for ERK1/2-dependent activation of FCHSD2 in cancer cell-selective regulation of clathrin-mediated endocytosis Article Snippet: The CK2 inhibitor TTP 22 (1 μM), the MLCK inhibitor ML-7 HCl (3 μM), the mTOR inhibitor rapamycin (10 nM), the p38 inhibitor SB239063 (450 nM), and the |

